Information Journal Paper
APA:
Copy. (2019). Chemotherapeutic agent paclitaxel mediates priming of NLRP3 inflammasome activation. FRONTIERS IN IMMUNOLOGY, 10(-), 0-0. SID. https://sid.ir/paper/1049722/en
Vancouver:
Copy. Chemotherapeutic agent paclitaxel mediates priming of NLRP3 inflammasome activation. FRONTIERS IN IMMUNOLOGY[Internet]. 2019;10(-):0-0. Available from: https://sid.ir/paper/1049722/en
IEEE:
Copy, “Chemotherapeutic agent paclitaxel mediates priming of NLRP3 inflammasome activation,” FRONTIERS IN IMMUNOLOGY, vol. 10, no. -, pp. 0–0, 2019, [Online]. Available: https://sid.ir/paper/1049722/en